Avianca Holdings S.A., through its subsidiaries, provides passenger and cargo air transportation services in the United States, Central America and the Caribbean, Colombia, rest of South America, and internationally. It operates in two segments, Air Transportation and Loyalty. It also offers aircraft maintenance, crew training, and other airport services to other carriers. In addition, the company is involved in the ground operations for thirdparty airlines and aircraft leasing activities, as well as operates LifeMiles, a frequent flyer program. As of December 31, 2018, it operated a fleet of 190 aircraft, including 148 jet passenger aircraft, 30 turboprop passenger aircraft, and 12 cargo aircraft. The company was formerly known as AviancaTaca Holding S.A. and changed its name to Avianca Holdings S.A. in March 2013. The company was founded in 1919 and is headquartered in Bogotá, Colombia. Avianca Holdings S.A. is a subsidiary of BRW Aviation LLC....
+See More2019-08-09 18:35:00 Friday ET

Nobel Laureate Joseph Stiglitz maintains that globalization only works for a few elite groups; whereas, the government should now reassert itself in terms o
2024-04-30 09:30:00 Tuesday ET

With clean and green energy resources and electric vehicles, the global auto industry now navigates at a newer and faster pace. Both BYD and Tesla have
2022-02-22 09:30:00 Tuesday ET

The global asset management industry is central to modern capitalism. Mutual funds, pension funds, sovereign wealth funds, endowment trusts, and asset ma
2023-06-14 10:26:00 Wednesday ET

Daron Acemoglu and James Robinson show that good inclusive institutions contribute to better long-run economic growth. Daron Acemoglu and James Robinson
2019-10-17 08:35:00 Thursday ET

The European Central Bank expects to further reduce negative interest rates with new quantitative government bond purchases. The ECB commits to further cutt
2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic